Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Interest Received Chart
PT Metro Healthcare Indonesia Tbk Interest Received Calculation
A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Received represents interest received by the company in the direct cash flow method.
Interest Received for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp15,323 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Received of Rp15,323 Mil mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Interest Received of Rp15,323 Mil as of Jun. 2026. Interest Received represents interest received by the company in direct cash flow method. View historical data for PT Metro Healthcare Indonesia Tbk and its competitors.
Is PT Metro Healthcare Indonesia Tbk's Interest Received too high?
PT Metro Healthcare Indonesia Tbk's current Interest Received is Rp15,323 Mil. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Interest Received compare to HCA and THC?
PT Metro Healthcare Indonesia Tbk's Interest Received of Rp15,323 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Received for a Healthcare Providers & Services company?
A good Interest Received depends on the Healthcare Providers & Services industry context. However, Interest Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Received mean?
A high Interest Received can signal that a stock is expensive relative to its fundamentals. Interest Received represents interest received by the company in direct cash flow method. View historical data for PT Metro Healthcare Indonesia Tbk and its competitors. PT Metro Healthcare Indonesia Tbk's current Interest Received is Rp15,323 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp364.12, compared to a current price of Rp424.00 — trading 16.4% above its estimated fair value. The current Interest Received is Rp15,323 Mil. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Received calculated?
Interest Received is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Interest Received is Rp15,323 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp424.00 is trading 16.4% above its estimated GF Value™ of Rp364.12.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
Interest Received: Rp15,323 Mil
GF Value™: Rp364.12 vs. price of Rp424.00 (16.4% above fair value)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
73GF Score
Get the complete analysis for ISX:CARE
Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
